These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 12718746)

  • 21. C-reactive protein inhibits plasmacytoid dendritic cell interferon responses to autoantibody immune complexes.
    Mold C; Clos TW
    Arthritis Rheum; 2013 Jul; 65(7):1891-901. PubMed ID: 23576062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgE Inhibits Toll-like Receptor 7- and Toll-like Receptor 9-Mediated Expression of Interferon-α by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus.
    Khoryati L; Augusto JF; Shipley E; Contin-Bordes C; Douchet I; Mitrovic S; Truchetet ME; Lazaro E; Duffau P; Couzi L; Jacquemin C; Barnetche T; Vacher P; Schaeverbeke T; Blanco P; Richez C;
    Arthritis Rheumatol; 2016 Sep; 68(9):2221-31. PubMed ID: 26991804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1β and LFA-1.
    Hagberg N; Berggren O; Leonard D; Weber G; Bryceson YT; Alm GV; Eloranta ML; Rönnblom L
    J Immunol; 2011 May; 186(9):5085-94. PubMed ID: 21430220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjögren's syndrome autoantigen-associated RNA.
    Lövgren T; Eloranta ML; Kastner B; Wahren-Herlenius M; Alm GV; Rönnblom L
    Arthritis Rheum; 2006 Jun; 54(6):1917-27. PubMed ID: 16729300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The innate immune system in SLE: type I interferons and dendritic cells.
    Rönnblom L; Pascual V
    Lupus; 2008 May; 17(5):394-9. PubMed ID: 18490415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
    Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
    J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7.
    Savarese E; Chae OW; Trowitzsch S; Weber G; Kastner B; Akira S; Wagner H; Schmid RM; Bauer S; Krug A
    Blood; 2006 Apr; 107(8):3229-34. PubMed ID: 16368889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
    Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
    Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-interferon alpha treatment in SLE.
    Kirou KA; Gkrouzman E
    Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.
    Garcia-Romo GS; Caielli S; Vega B; Connolly J; Allantaz F; Xu Z; Punaro M; Baisch J; Guiducci C; Coffman RL; Barrat FJ; Banchereau J; Pascual V
    Sci Transl Med; 2011 Mar; 3(73):73ra20. PubMed ID: 21389264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus.
    Oon S; Huynh H; Tai TY; Ng M; Monaghan K; Biondo M; Vairo G; Maraskovsky E; Nash AD; Wicks IP; Wilson NJ
    JCI Insight; 2016 May; 1(6):e86131. PubMed ID: 27699260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
    Vallin H; Perers A; Alm GV; Rönnblom L
    J Immunol; 1999 Dec; 163(11):6306-13. PubMed ID: 10570325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor activation in the pathogenesis of systemic lupus erythematosus.
    Means TK; Luster AD
    Ann N Y Acad Sci; 2005 Dec; 1062():242-51. PubMed ID: 16461805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases.
    Berggren O; Alexsson A; Morris DL; Tandre K; Weber G; Vyse TJ; Syvänen AC; Rönnblom L; Eloranta ML
    Hum Mol Genet; 2015 Jun; 24(12):3571-81. PubMed ID: 25779693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolic acid, the active form of mycophenolate mofetil, interferes with IRF7 nuclear translocation and type I IFN production by plasmacytoid dendritic cells.
    Shigesaka M; Ito T; Inaba M; Imai K; Yamanaka H; Azuma Y; Tanaka A; Amuro H; Nishizawa T; Son Y; Satake A; Ozaki Y; Nomura S
    Arthritis Res Ther; 2020 Nov; 22(1):264. PubMed ID: 33168076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of litifilimab (BIIB 059) for cutaneous and systemic lupus erythematosus.
    Cho YM; Furie R
    Immunotherapy; 2024 Jan; 16(1):15-20. PubMed ID: 37877249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor.
    Kono DH; Baccala R; Theofilopoulos AN
    Autoimmunity; 2003 Dec; 36(8):503-10. PubMed ID: 14984027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.